You just read:

Orexigen Therapeutics Announces Commercialization and Distributorship Agreement with Consilient Health Ltd. for Mysimba® (naltrexone HCl / bupropion HCl prolonged release) in the UK and Ireland

News provided by

Orexigen Therapeutics, Inc.

08 Dec, 2016, 07:25 ET